Wegovy / Ozempic (Semaglutide)

Semaglutide is a medication used to manage type 2 diabetes and obesity. It helps lower blood sugar levels. It is also used to help people lose weight.

Brand names:Ozempic, Rybelsus, Wegovy
Medication

What people taking Wegovy / Ozempic (Semaglutide) report

Every report comes from a Lived member, sent anonymously.

Have you tried Wegovy / Ozempic (Semaglutide) for Obesity?

NameHow it went

About Wegovy / Ozempic (Semaglutide)

What It's For

Semaglutide is the active ingredient in Ozempic and Wegovy, prescription medications with different approved uses. Ozempic treats type 2 diabetes in adults. Ozempic injection also reduces the risk of major heart-related events in adults with type 2 diabetes and established heart disease, and helps protect kidney function in adults who have both type 2 diabetes and chronic kidney disease. Wegovy is approved for long-term weight management in adults with obesity, or overweight plus a weight-related health condition, and in adolescents 12 and older with obesity (injection only). It also lowers the risk of heart attack, stroke and cardiovascular death in adults with established heart disease who have obesity or overweight. Wegovy injection has accelerated approval for adults with MASH (an inflammatory fatty liver disease) whose liver has moderate to advanced scarring but not cirrhosis. That approval rests on early liver results, and confirming studies continue. Although both brands contain semaglutide, their doses, formulations and prescribing instructions differ, so they should not be substituted for one another without guidance from the prescriber, or combined with each other or another GLP-1 medicine.

How It Works

Semaglutide mimics the effects of GLP-1 (glucagon-like peptide-1), a hormone the body releases after eating. It acts on appetite-regulating pathways in the brain, slows stomach emptying and helps the pancreas release insulin when blood sugar is elevated. People often feel satisfied with smaller meals, which can lead to weight loss over time. In people with diabetes, it also helps lower blood sugar.

Dosage & Administration

Ozempic and Wegovy injections are given once a week under the skin with a prefilled pen, which is never shared, even with a new needle. Semaglutide also comes as a once-daily tablet: Rybelsus and Ozempic tablets for type 2 diabetes, and Wegovy tablets for weight management. Every form starts at a low dose that is usually increased about monthly to help the body adjust. The tablets are absorbed poorly unless swallowed whole first thing in the morning on an empty stomach with a little plain water (no more than 4 ounces), then nothing to eat, drink or swallow for at least 30 minutes. Because dosing differs substantially across products, and tablets and injections are not interchangeable milligram for milligram, follow the prescription for the exact formulation rather than copying another person's regimen. Changes in dose should be made with the prescriber.

Side Effects

Nausea, vomiting, diarrhea, constipation and abdominal discomfort are the most common side effects, particularly after starting treatment or increasing the dose. Many improve as the body adjusts. Smaller meals and slower eating may help with tolerability. Persistent vomiting or diarrhea, or inability to keep fluids down, warrants prompt medical advice. Severe abdominal pain that does not go away means stopping the medicine and calling the prescriber right away, because it can occasionally indicate pancreatitis or a gallbladder problem rather than an ordinary medication side effect.

Interactions & Warnings

Every semaglutide product carries a boxed warning: it caused thyroid tumors in rodents, and whether it does in people is unknown, so it is not prescribed to people with a personal or family history of medullary thyroid cancer or the inherited condition MEN2. Tell the prescriber about a lump or swelling in the neck or hoarseness that persists. Animal studies suggest semaglutide could harm a developing baby, and it stays in the body for weeks, so it is stopped at least 2 months before a planned pregnancy. Anyone who becomes pregnant while taking it should tell the prescriber promptly; Wegovy taken for weight is stopped in pregnancy. The tablets contain an absorption-boosting ingredient that passes into breast milk, so breastfeeding is not recommended while taking them. The injections do not contain it; whether to breastfeed while using one is a decision to make with the prescriber. Combined with insulin or a sulfonylurea, a type of diabetes pill, it raises the risk of low blood sugar, so the other medicine's dose may need lowering. It is not recommended for people with severe gastroparesis (very slow stomach emptying), because it slows emptying further. Tell the anesthesia team before any procedure involving sedation or general anesthesia, because slowed stomach emptying raises the risk of food entering the lungs. Use only an appropriately prescribed product from a licensed pharmacy; compounded versions are not FDA-approved, and dosing errors with them have been reported.

What to Expect

Appetite changes may begin early, but weight loss generally develops over months as doses increase. Results vary considerably. In the 68-week trials of Wegovy injection, adults without diabetes lost about 15 percent of their body weight on average (about 2 percent on placebo), and adults with type 2 diabetes lost about 10 percent. Medication is most useful alongside sustainable eating and activity habits. For many people it is a long-term treatment; weight regain is common after stopping. People using it for diabetes will also track blood sugar and, when relevant, heart, kidney or eye health. Follow-up visits help assess both benefit and tolerability.

Questions to Ask Your Doctor

  1. 1.Which product fits my goals and history, a weekly injection or a daily tablet?
  2. 2.What results should we realistically expect, and over what period?
  3. 3.How should we handle nausea or other problems during dose increases?
  4. 4.Do my pregnancy plans or other diabetes medicines need to change before I start?
  5. 5.If I eventually stop taking it, what would the long-term plan look like?

Last reviewed • Oct 2026

Educational content, not medical advice.